Analytical consistency for 24 months Maintain structural integrity for 30 days Complete observation within 24 hours GHK-Cu is a naturally occurring copper-tripeptide (glycyl-L-histidyl-L-lysine bound to copper) first identified in human plasma in 1973
Conclusion This study reviews a variety of therapeutic peptides and targeting ligands in cancer therapy
Third-Party Tested: Independent HPLC and mass spectrometry verification on every batch
Preparation records should include product name, lot number, solvent, target concentration, date prepared, storage temperature, operator initials, and intended assay
Non response to B12 injections should therefore necessitate re-evaluation and consideration of other diagnoses
Research-grade peptides ordered online without prescription are not equivalent in safety or quality